The FDA’s Regulatory Framework for Chimeric Antigen Receptor‐T Cell Therapies

Lignende værker

• The Long Road to the First FDA Approved Gene Therapy: Chimeric Antigen Receptor T Cells Targeting CD19
  af: Braendstrup, Peter, et al.
  Udgivet: (2020)
• Chimeric antigen receptor T cell therapy for multiple myeloma
  af: Hasegawa, Kana, et al.
  Udgivet: (2019)
• Mechanisms of failure of chimeric antigen receptor T-cell therapy
  af: Li, Xiaoqing, et al.
  Udgivet: (2019)
• Chimeric antigen receptor T cell therapies for multiple myeloma
  af: Wu, Chao, et al.
  Udgivet: (2019)
• Chimeric Antigen Receptor T-Cell Therapy for Multiple Myeloma
  af: Hosen, Naoki
  Udgivet: (2019)